semaglutide hepatotoxicity case report Effect of on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity Liver decompensation after rapid weight

Always loop your doctor or dietitian in before making significant changes

These drugs include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity for diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for weight management)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not solely a GLP-1 agonist

Each semaglutide brand or formulation is FDA-approved for specific conditions and patient populations

9 July 2025

So, continuing to address those (with diet, therapy, etc.) in parallel is important